Federal contract award

31310024C0009

SUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyNuclear Regulatory Commission
OfficeNUCLEAR REGULATORY COMMISSION
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCQ527 — Nuclear Medicine
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeTIME AND MATERIALS
Obligations$659.0K
Current contract value$1.5M
Potential contract value / ceiling$2.6M
Start dateJun 10, 2024
Current end dateJul 31, 2027
Potential end dateJul 31, 2029
Latest award activityAug 7, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 7, 2026P00010$100.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Aug 5, 2026P00009$134.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Jul 1, 2026P00008$0SUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
May 11, 2026P00007$50.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Apr 1, 2026P00006$50.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Dec 15, 2025P00005$40.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Jul 29, 2025P00004$50.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
May 28, 2025P00003$40.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Mar 20, 2025P00002$55.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Nov 7, 2024P00001$100.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.
Jun 10, 20240$40.0KSUPPORT AND DEVELOPMENT FOR DOSIMETRY ANALYSIS AND COMPUTATIONAL TOOLS FOR LICENSING AND INSPECTIONS.

Estimated positioning window

Jul 31, 2028 – Jan 31, 2029

Recompete signal:
45/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 45/100. Available recorded signals: 40 points.

Contract end 2029-07-31 (1010 days from calculation)
+15 points
1 historical awards in this buyer and category group
+0 points
11 recorded award transactions
+10 points
Latest award action: 2026-08-07
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
COLEMAN, GEOFFREYContactGeoffrey.Coleman@nrc.gov
301-415-5517
SourceMar 27, 2024

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Check the stated set-aside against the solicitation and current certifications.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.